ARCHIVES INTERNAL MEDICINE www.archinternmed.com Index to Volume 161 January through December 2001 Editor James E. Dalen, MD, MPH 1840 E River Rd, Suite 207 Tucson, AZ 85718 Deputy Editor FarrellJ . Lloyd, MD, MPH Scottsdale, Ariz Associate Editors Frederick R. Ahmann, MD Tucson, Ariz RobertJ . Goldberg, PhD Worcester, Mass Eskiid A. Petersen, MD Tucson, Ariz Editorial Assistants Christine Despres Janet S. Frank Tucson, Ariz Editorial Board Joseph S. Alpert, MD, Tucson, Ariz John P. Howe III, MD, San Antonio, Tex Christine K. Cassel, MD, New York, NY Richard S. Liebowitz, MD, Durham, NC William S. Dalton, MD, Tucson, Ariz Jack M. Matloff, MD, Los Angeles, Calif M. Brian Fennerty, MD, Portland, Ore Raymond Taetle, MD, Tucson, Ariz Faith T. Fitzgerald, MD, Sacramento, Calif ARCHIVES INTERNAL MEDICINE www.archinternmed.com Index to Volume 161 January through December 2001 Editor James E. Dalen, MD, MPH 1840 E River Rd, Suite 207 Tucson, AZ 85718 Deputy Editor FarrellJ . Lloyd, MD, MPH Scottsdale, Ariz Associate Editors Frederick R. Ahmann, MD Tucson, Ariz RobertJ . Goldberg, PhD Worcester, Mass Eskiid A. Petersen, MD Tucson, Ariz Editorial Assistants Christine Despres Janet S. Frank Tucson, Ariz Editorial Board Joseph S. Alpert, MD, Tucson, Ariz John P. Howe III, MD, San Antonio, Tex Christine K. Cassel, MD, New York, NY Richard S. Liebowitz, MD, Durham, NC William S. Dalton, MD, Tucson, Ariz Jack M. Matloff, MD, Los Angeles, Calif M. Brian Fennerty, MD, Portland, Ore Raymond Taetle, MD, Tucson, Ariz Faith T. Fitzgerald, MD, Sacramento, Calif In this index in alphabetical order are listed names of authors of all art icles and letters. Full citation is given under first author only; reference is made from joint authors. Names which begin with a prefix are entered under the prefix M, Imai H, Etchason J Abookire SA, Karson AS, Fiskio JM, Bates DW Armstrong PW see Massie BM Arnett FC see Johnson RW Arnold JMO see Tsuyuki RT Meier DE Abraham M see Khardori R Aro A see Erlund I s IM, KuchibhatlaM N, Weng HH, Halab Abrahamowicz M see Han | Aromaa A see Knekt P PD, Skinner CS, Rimer BK Abramson J, Berger A, Krumholz HM, Vaccarino V Artner C see Finsterer J Asch SM, Kerr EA, LapuertaP , Law A, McGlys Bates DW see Abookive SA; Field TS; Rothschild JM n A, Johnston M, Naguit I, Kov Achard JM see Fournier A Ackermann RT, Mulrow CD Ashburn TT, Eisenstein BI Johnston M, Hirsh ] Ackermann RT Mulrow CD, Ramirez G, Gardner CD Ashley JM, St Jeor ST, Schrage JP, Perumean-Chaney SE Morbidoni | Lawrence VA a shows pr s GilbertsonM C, McCallN L, Bovee \ Adair NE see Knower MT Aslam N, Marino CR L, Nybo H, Ranberg KA Adams-Huet B see Rubin CD Vaupel J,C hristensen K Addy BE AstraZeneca Arthroplasty Study Group s« Agnetti B see Dazzi D ATHENA Project see Nieuwkerk PT Agostini JV, Leo-Summers LS, Inouye SK Atlas S] see Dedier J Attia J, Ray JG. Cook DJ Douketis seerts WH Aguiar-Garcia F see Trujillo-Santos A] Ahronheim JC see Meier DE Atwood E see Lipinski M Ain KB see Ladenson PW Au WY, Jim MH, Lam KY, Kwong Y AjaUnAi s ee LotufoP A Alberts A see Baron JA Au WY see KwongY I man DM Albertson GA see Lin C-1 Avants SK, Margolin A, Holford TR, Koster lagnusF Albrecht H, Lennox J, del Rio ¢ M, Fahrenbruch C, Cobb I Alexander J see Jiang W Avezum A Jr see Tsuyuki RT Alexopoulu A, Michael A, Dourakis SP Avins AL, Neuhaus JM s M, Every N, Maynard (¢ Frederick F re JM, Lambrew C, National Registry Aviv A farction Participants Alfthan Gs ee Erlund I; Knekt I Ali MN see Levine GN Avor|n s ee Field TS; SolomonD H Allen CV Aydogan H see Ulkar UGB Ayo DS see Branca P Allman R see Lyder CH AzRa sere Biell RA Allum A see Manning Pj Alr n D see Ruiz-Garcia \ Alper PR see Chehab El Beie M sex Alpert JS, Flanagan DM, Botsford NA BBaacchiee wirickz PSA M,s ee BaClui BSY Beiser A see Seshadri Beitsch LM see Barr Kravitz R hom D, Krupat E, Azari R Alt M see Andrés E Baden L see Solomon DH Altieri E see Manfredini R Bagchi N see Ladenson PW Aleman DE see Blendon RJ Bailey WC see Wirt DP Altman RD see Tan Bajjoka AE: Dalter warfa Alvarez S see De Jose MI ner K see AAnmdberroszoyn DDMR sseeee WRaeyn riJcGh MD Baker— ——D W, Sheattperi) ro M12F8, Schur Cl Bensefior IM Anderson GD see Heckbert 5R Baker LC see Chehab EL Benser M se Fiieledl d TT S Anderson GM see Jackevicius CA Bakris GL: Practical appr Benson JM see Blendon RJ Anderson M see Psaty BM t 1 pressure goals AAnnddeerrssoonn RSJN sesee e LLiinn CC--TT BBaall adByS sGeje sBeea ciDeawviicdzo ff AMR A se Andrés E, Maloisel EA: Antit nd 1 agrar Bandini L see Dazzi D ger BW see Gomes-Solecki MJ¢ sisa: mo nocentric study of 2 uses. 2619 Bannwarth B: Are ¢ r C see Johnstone D Andrés E, Perrin A-E, Alt M, Goichot B, Schlienger J-I al NSAIDiSn acute pains r M see Markswn LE AngFeelb riEl e seep anWcyevitnobr erg » M associated with pidogrei, 12 BBaarrabna raD AG sseeee GDoem bGeirogrg-iMoa itR land M Bergerons t |lD sseee e LeHumlile uxR D |; Pirro M Ansell BJ: Appropriate { Barge J see Pouchot J Bergstrom Ns ee Lyder CH Barlow W see Cherkin DC vist D see Hull RD Antman EM see Turpie AGG Barnes D see Yaffe K rkowitz RI see Wadden TA AppelL J: Is salt so harmful f Barnhill KE, Beitsch LM, Brooks RG Berkowitz SD se« Heit JA Bernabei R see Landi F; Onder G; Zuccala G Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S : { mport Bernard P-M see Pirro M Lacy CR: Effe fr 1 m intake on hyz Barnstedt S-E see Bork K Berrebi A see Klepfish A Baron JA, Farahmand BY Weiderpass FE Michaeélssor Bertolini A see Grandi AM K, Alberts A, Persson I, Ljunghall S g Bielak LF see Nallamothu BK i VE 6 ) ng, a I nsumption, . and r" isk f} Biggerstaff SL see Padilla R Appel LJ see Erlinger TP BigoSTs s ee LadensonP W Applegate WB see Penninx BWJH Baroody FM see Kaszuba SM Birkenhager WH, Forette F Seux M-l Wang J-< Archer D see Rebar RW Barretto ACP see Tsuyuki RT Staessen JA s ‘ Ariza | see Capdevila O Bartlett JG see Musher DM Armour BS, Pitts MM, Maclean R, Cangialose C, Kishel Barzon L see Boscaro M ARCH INTI RN MED/VOL 161, DEC 10/24, 2001 WWW. ARCHINTERNMEI 2751 Birnbaum HG, Morley M, Greenberg PE, ¢ bre »die M see Blendon Rj handra KMD, Parish DC, Dane F¢ Colice GL: Ecor r Bre »ggi R see Grandi AM employed populatior Bre »0k RH see Diamant Al see Chou C-W Bishai WR see Golub JE Bre »0kDs s ee Lacasse Y F. see Dedier ] Bishop L see Wald DS Br »0ks RG see Barnhill KE Chatellier G see Bobrie G Bitterman H see Rubinshtein R Bre srs O see Ebbesen J hater S see Wilson KG Blair C see Kaszuba SM Bre ywner WS see Frances CD Chee E see Farup ¢ Blais L, Desgagné A, LeLorier J Bre ywningR , JacksonJ L, O’Malley PG: ¢ eesman RA see Hoff TH e risk of cance l kp 1-analysis, 161] hehab EL, Panicker N, Alper PR, Baker LC, Wilson SR Blakely JA: Increas ronary Brudy-Gulphe L see Péne F RaffinTA : Impa or settir n phys nf Bruera ED see Lawlor PG f a { pra and patient car Blanche P see Zompi S Bruwer A: Ir re of pa Blanco JR see Mufioz P Bryan RN see Psaty BM G see Lankipalli RS Blazing MA see Jiang W; Whellan Dj Bu ajordet I see Ebbesen J] T see Krumholz HM Blazquez R see Moreno S Bu chter CM see Costantini O ) st-effe r Biendon RJ, DesRoches CM, Benson JM, Brodie M Bu enaver M see Ziegler DK Altman DE: Americans VS I i g Bu gés | see Rodriguez E tior lietary supplements, 8 Bu ist AS see Markson LE isenberg D, Sherman KJ, Barlow W Bloemenkamp KWM, Helmerhorst FM, Rosendaal FR Bu la CJ, Wietlisbach V, Burnand B, Yersin B Street J,D eyoR A Vanderbroucke JF f € t e debate cor erning thir ne nor s s utilization in elderly medical inpatien nassag ind s thrombosis tte Bu llock C see Sheikh K a 8 Bloigu A see Seppa Y Bu rger DM see Nieuwkerk PT h see Nieuwkerk PT Blot WJ see Kjoller K Bu ring JE see Lotufo PA W, Earl]: M Blum S see Turett GS Bu rnand B see Bula CJ f ng ar nt Blumenthal RS see Cui Y Bu rns M see Becker RC Boari B see Manfredini R Burval D] see Dumot JA Chey WD, Fendrick AM Bobrie G, Genés N, Vaur L, Clerson P, Vaisse B, Mallion Bush TL see Cui Y gf J-M, ChatellierG : Is “isolated home” hyperter 1as OF Butcher MS see Hull RD sess Buyukberber S see Sevinc A Chey WY see Camilleri M By tzer P, Talley NJ, Leemon M, Young LJ mes MI hibnall JT, Jeral JM, Cerullo MA Bock SA see Sicherer SH Horowitz M: Prevalence of gastroint Bocola V see Di Napoli M Bodey GP, Hanna HA, Raad II: F R Jr see Knower MT hinellatoM see Valle R Boehnlein JK see Richardson RD F see Fass R Bogdan GM see Dart RC; Kuffner EK xchinov HM Bonfiglio MF see Basch EM abana M see Cruz orrea M quet-Kastylevsky G, Kanitakis J Bookwala J] see Ditto PH aidahl K see Omland T ire M Claudy A Bootsma-van der Wiel A see von Faber alderwood SB see Mylonakis E Bordon J see Ramirez JA aldwell ES see Curtis JR Bork K, Barnstedt S-E alich I see Iriya SM geal edema with C! inhibit aliff RM see Jiang W hereditary a edema, 714 amilleri M, Chey WY, Mayer EA, Northeutt AR, Heat Bornstain C see Hocqueloux A. DukesG E, McSorley D, Mangel AM: R ( Bortz WM Il a r . . f shee oon den oun ter ' Bathum yon \ irist n Bathum | Boscaro M, Barzon Sonino N thle bow ndron ri E see JiangW ampion K see Lalezari J rmbaum H( Botsford NA see Alpert JS ampo-Angora M see Martin-Fernandez Weaver M Bottorff MB, Hansten P: Safety amps MIL see Geerlings SE ubotaru M see Rubinshtein R andy GP see Sareli P ark BD see Krishnan JA angialose C see Armc BS ark R k al re i annon CP see O'Rourke RA Bounameaux H see Perrier A; Wicki ] antiBn s ee Lemieux I; Pirro M + Bourassa MG see Schwartz | anto MI see Cn Correa M Clark RF see Dart R« Bourgault C, Rainville B, Suissa S anzanello VJ, Jensen PL Schwartz GI lio GA. Martin AF. Perrin herapy Saskatchewan: |} ants in } : » 187 vA see ( hoquet Kastylevsky (¢ Bourke DL see Dumot JA J HertzmanP A Bourne D: Inform ar t Jc see Massie BM P see Bobrie G Bouvy ML, Heerdink ER, De Bruin ML, Herings RM¢ k N see Snoeck R Leufkens HGM, Hoes AW apelozzi VL see Iriya SM EH see Field AE wa me arrhvtk arbonin P see Zuccala G ( I Becker I Bouza E see Munoz P ariou A see Péne F A see ZuccalaG Bovee V see Ashley JM arline JD see Wenrich MD sin W see GolubJ E Bowen Dj see Davidoff R arll son MD see Costantini O HD see Ladenson PW Bowers W] see Wirt DP Carpena I see Morer shen IS Bowlus CL see Leigh JP arrerGa sse e Pérez A Bowman MA see Glazier MG arrillo-Jimenez R, TreadwellR C, Zogby M Boyd K see Costantini O Boyer EG see Farber NJ arroll RM see Spellberg B Boyer LV see Dart R¢ arson P, Nichol KL, Janoff EN: Imr Bozkurt AK ease is q nable tle arvalho ACC see Tsuyuki RT Bradley EH see Fried TR asper E see Kuffner EK Branca P, Rodriguez RM, Rogers JT, Ayo DS, Moyers JP aspiO : Possit ar Light RW: | measais uret er f pleura f 1 lase t ndicated 8 astorina | see Weaver M Brancati FL see Coresh ] atalan VS, Couture JA, LeLorier J Weg v, is not alwa Brant RF see Hull RD f fther | antidiabetic age yhen MC see O'Rourke RA Brass E see Spellberg B attaneo M Ist pernom ysteinem Cohen MH see Ernst E Brehler R, KuttingE er ary heart d shn JN: I emit re serur ncentra nterdisciplinary concern in medicine, 1 Cavazzini C see Penninx BWJH ; tify potassium adn sratios Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J: Rar ebul SA see Wolfe SA Colditz GA see Field AE; Hu FB; Karlson EW nized uble-blind, placeb ed trial ps ecconi A see De Giorgio R ole M see Han I lampuilat elentano DD see Strathdee SA olice GL see Birnbaum HG Timmun defi iency Virus disease sé ernieux |] see Yood RA ollazos J, Mayo J, Ibarra S, Martinez E Brennan C see Vergis EN sd erullo MA see Chibnall JT t resulting from acute sever Brennan PJ] see MacCallum PK ( esana BM see Fraquelli M mised patients is n Brett AS ( esari M see Landi F; Onder G al number of lymphocyte Dementia ymy tubes, and mortality (letter C hadenat M-L see Morelon S ollet JT see Geerlings SE Informed sent and the placement of percutane ( hae CU see Lotufo PA olli A see Fraquelli M doscopic gastrostomy tubes (letter) 250¢ ¢ haisson RE see Golub JE ollier AC see Curtis JR Brett AS, RosenbergJ C Adequacy of informed € hallacombe S see Kassimos DG olombo S see Grandi AM placement of gastrostomy tubes, 745 ( han SY see Kearns P] Colopy M see Monto AS ARCH INTERN MED/VOL 161, DEC 10/24, 2001 WWW. ARCHINTERNMED.COM 2752 olwell CW see Heit JA on AH see Linden W onboy E see Yood RA A] see Lasater LM mstantine G see Davidoff R DaviglusM L see Miura K onte D see Fraquelli M Davis EB see Farber NJ Conway DSG see Makin Aj Davis K, Schoen Schoenbaum $ ook CB see El-KebbiIM : Miller CD ooDkJ] s ee Attia J Davis KD see Davidoff R ooney LM Jr see Inouye SK Davis MP, Walsh D oper GS ipa Davis RB see Wee CC ooper GS see Costantini O Dawson NV see Wolfe SA opland M, Walker ID, Tait R¢ Dazzi D, Agnetti B, Bandini | F, GhillaniM , Giacomi ¢ al fibrillatior b oppola KM, Ditto PH, Danks JH, Smuc ker WD De Becker P, De Meirleir K Coppola KM see Ditto PH De Becker P, Roeykens J, Reynders M, M oresh J, Wei GL, McQuillan G, Brancati FL, Lewey AS De Meirleir K Jones C, Klag MJ 160 Bie S see Loeys E Boer A see,Klunge!O H De Bruin ML see Bouvy MI orinaldesi R see De Giorgio R De Clereg E see Snoeck R orradini P see Dazzi D de Faye BJ see Wilson KG ostantini O, Huck K, Carlse: MD, Boyd K, Buchter CM de Geus C see Khan SA Raiz P, Cooper GS j ba De Giorgio R, Barbara G Mancini AM ouderc L-] see Zompi S vanni F se uillard C see Lemieux | ng PE an sedee r MoBnersgt er LTWT BMs ee Monster suncil on Scientific Affairs, American Medicz se MI, Ramos JT, Alvarez S, Jime ciation see Tan I urbon D see Zureik M Fernandez MA outure JA see Catalan VS vinsky K see Yaffe K De Maubeuge J see Sno randall ¢ De Meirleir K s rane P see Fass R le Moerloose ronin WA see Golub JE De Paepe A ‘ oeys B ruz-Correa M, GrossC P, Canto MI, Cabana M de Vries M der Horst Sampliner RE, Waring JP, McNeil-Solis C, Powe NR de Wo Nieuwkerk PT Deacor Kearns P] rystal RG see Wisnivesky J DeAngelis CD, RosenbergR N, Smith JM Cuffe MS see Jiang W; Whellan D] ui Y, Blumenthal RS, Flaws Whiteman MK DECODE Study Group, European Diabet Langenberg P, Bachorik PS, Bush TI indiff DK inha BA unningham JP see Nasca TJ urry SC see Dart RC: Tanen DA egirolami PC see Sakoulas ¢ urtis TR. Patrick DI, Caldwell ES. Collier AC ee Albrecht H Munhoz P urtisJ R see Wenrich MD ue M-H see Zompi S urtis K see Solomon DH D’Elia JA, Weinrauch LA, G ushman M see Psaty BM Keou Pendse 5, Roshar ymet T yran EM see Lin ¢ Delli Gatt see Manfredini R D Delvaux I Loeys B Demiray T see Ulkar UGE DagenaisGR see Lemieux |; Pirro M Den Hond E see Sareli F gostinoRB see Lloyd-Jones DM; Seshadri S; Worz Desbiens NA see Zoch TW DesbiensN A, Zoch TW, DeStefano F, I Jahl OE see Hull RD Jalen JI Descotes J] see Choquet-Kastylevsk 160 Desgagneé As ee Blais I Després J-P see Lemieux 1; Pirro M alessandri KM: f DesRoches CM see Blendon RJ DeStefano F see Desbiens NA; Zo ™ Jane FC see Chandra KMD deTineo M see Kaszuba SM Janiels GH see Ladenson PW Deyo RA see Cherkin D¢ Yanks JH see Coppola KM; Ditto PH Dhossche DM, Ulusarac A Yanner SA see Nieuwkerk PT Dansuk Z see Ulkar UGB Jart RC see Kuffner EK Di Napoli M, Bocola V, Papa I dartR C. SeifertS A, BoyerL V, Clark RF, Hallf McKinney P, McNally J, Kitchens CS, Curry SC, Bog Diamant AL, Brook RH, Fink A, Gelberg I dan GM, Ward SB, Porter RS: Randomized mt ter trial of salinee polyvalent immune fal Diaz J see Luna \ snakebite in tt ted S DiBari M see Penninx BWJH Jarton L see Kuffner EK Diette GB see Krishnan JA; Wu AW Yattwyler RJ see Gomes-Solecki MJC Dietz WH see Field AE Javenport C see Jiang W Dimitrov V see Murtaza M Davidoff R, McTiernan A, Constantine G, Davis KD, Balady Dissin ] see Tanvetyanon T sason | ¢ Armou GJ], Mendes LA, Rudolph RE, Bowen Dj hocardi Ditto PH, Danks JH, Smucker WD, Bookwala J ninan M. Takkouche f graphic examination of women previously treated with Coppola KM, Dresser R, Fagerlin A, Gready RM ARCH INTERN ME D/VOL 161, DEC 10/24, 2001 WWW. ARC 2733 . rf ; 160-2645 Francis CW see Heit JA; Hull RD European Diabetes Epidemiology Group see DECODI Franco-Paredes C, Evans J, Jurado R: Di Study Group rey isp neumoniae menit Evans A, Kalra l Franklin B see Lipinski M Fraquelli M, Losco A, Visentin S, Cesana mite D: Gal Evans | see Franco-Paredes ( n disease ; Rollman BI Every N see Becker RC s 01 Gilberts« see Ashley JM Evesti P see Kotilainen P FraserG E, ShavlikD J: Ter f silchrist see WilkinsonT J JS, Hirsh J, Julian J, Vander LaandeVries M Frederick Ps ee Becker R¢ Magier D, MacKinnon B, Gent M: Prevention and tr Fried TR, Bradley EH, Williams bit lrome: r f Fagerlin A see DittoP H Fahrenbruch C see Becker | nsberg JS s Attia |; Bates SM: Heit JA Falguera M, Sacristan O, Nogués A, Ruiz-Gonzalez Friedman J see Schattner A enia C, Pagano L, Leone G, Martino P Garcia M, Manonelles A, Rubio-Caballero M Friedman P see Goldschlager N la krusei fungen t Friedmann PD, McCullough D, Saitz RS sirod JP see Singh S veen ca ur rity or m t f lrug abuse H D see Gomes-Solecki MJ¢ Farahmand BY see Baron JA | ) physicians and psychiatri slazer G ng n pharma Farber NJ, Davis EB, Weit.er ], Jordan J, Boyer EG, Ubel Friedmann PD see Samet JH ' ale PA: Physicians’ attitudeasb out involvement Frigas E see NzeakoU C azier MG, Bowman MA: R tion for capita Friis S see Kjoller K rogens as ar Farcet J-P see Zompi S FrisoGnB is ee RozziniR nent tf Farup C, Kleinman L, Sloan S$, Ganoczy D, Chee Froelicher V see Lipinski M eason RE see D’EliaJ A C, RevickiD : Impact Frost L, EnghoimG , Johnsen SP, Moller H, Henneberg EW nn RJ see Solomon DH Husted S He Irom mb bi M see Mennini T } caiicinbanie wail ad extremity a1 soethe B see Weinberg M Fass R, Longstreth GF, PimentelM , Fullerton S$, Russak I i » B, Grunenberger F, SchliengeJr- l SM, Chiou C-F, Reyes E, Crane P, Eisen G,M cCarberg j B, Ofman J]: | ’ nd cons¢ 1 pra Frost L, Johnsen SP, Engholm G, Henneberg EW, Huste ;oichot B see Andrés F S:s 1 nboembolism in atrial f vid HS see Sakoulas G idberg RJ see McCormick D; Yarzebski j Faulks JT see Drinka P Frothingham R r rcomm y-a Idmann DA see Weinberg M Faure M see Choquet-Kastylevsky G nia r) 165 ;oldschlager N, Epstein A, Friedman P, Gang E, Kroi R Federman DG, Kirsner RS pdat Fryzek J see Kjoller K Ishansky B, North American Society of Pacing and Fuchs FD see Gus M Electrophysiology (NASPE) Practice Guideline Com Feingold RM: Thought! FuentesJ M see Weinberg M mittee nent r r ts on patier mes (letter) | Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T ~e and Feinstein AR see Hertzman PA tyr liabetes with DIDM . Feit S, Rubinstein Sf Feldman Jj see Loria CM Fullerton S see Fass R roldschlager N, Practice Guidelines Subcommittee Fellenius C see Hull RD Funesti-Esch J see Breithart W North American Society of Pacing and Electrophysiol Fendrick AM see Chey WD; Nallamothu BK Fung TT, Willett WC, Sta mpfer MJ, Mansor t g Y ror | t rt } li - Ferber KL see Mundt |¢ e risk of nary | Ferreira I see Lacasse Y vor 8 soldstein MR Field AE, Coakley EH, Must A, Spadano JL, Laird N Furberg CD see Heckbert SR; KlungelO H; P Dietz WH, Rimm EB, Colditz GA: Impa Fuster V see Gomberg-Maitland M NM, =» aKfo l& lveenifMlH , WDicafimorr d S, aGnaneg e BF ‘ weight— o_—n the . risk ofar dpeerv eloping Q 4 pulmonar FieEldc kleTSr, GM,u rwBietnzs erJ H M, AvoBrant esJ , MDWc:C ormFf ick D, Jain { S Gabay M, Lodolce A dstein RSr onseien LWaAc,a sseO bYa sanjoOO , Coggin W, Moore aoe j nt t Gage ! BF see ! Goldisort ein NM i WRD,S , ChTahiosmsposno n RE D, Sterling TR, Ha{ rrMiyncgotboacnt S Gagnon B see Lawlor PG shoves | » ca nt with an infe Fielder AR, Griffith R Gaist D see Bathum | 254 Fielline aDnA , te O'Ctoenn nor PwGo,b iomeRse id vMiCth alcot GGaailtaani N H see see StWreaithndbeeer g SAM rg-Maithleaartn d faMi,l ureB: ara¢n DA, nesF ustfeorr tVh:e Tprr i primary care setting (letter) 89¢ Gallerani M see Manfredini 7 heart failure sI p alist. 34 FFFiiinnnRkns e atdceLctAr i eenssneraeeetb iaocYnD]-h,oi ieuarrnm Ag ar nttmS$e T re dAlg ivCae,nr t K lcaeldlo seairrk te rnt A, nKdarlOoecn h mayr R GGGGGGaaaaaanllnnmgllj obiiicane zansEy sJ Ri SsD eLesD ese Ge e ssGeeoseeP e Hlie rdoeEFscslcaq -hLurKaleeunadblpLgiAbo e¢iur F x; IMON;| n deMirl leGr CD ooyGmnnnl eznazeas lslsl -eaSVs o J-lDRseJ,ecSee k iYaisgm e aePe anrMdJsgiCN ,lX a l,saEc DWas aoRee rt Tmt]sG rwerayerrll cieai GraRPb-J ,u: Vr gaPdFl :ed resicnags asDH-,C aBmepreglero BEW Fischione MA see Tanen DA Gans R see de Vries M Gonzalez-Hermoso C see Trujillo-Santos AJ Fish L see Yood RA Garcia E see Munoz P Gonzalez-Reimers E, Santolaria-Fernandez F, Garcia Fiskio JM see Abookire SA; Rothschild JM Garcia M see Falguera M Valdecasas-Campelo E, Rodriguez-Rodriguez E, Lopez Fitterman L see Markson LE Garcia-Valdecasas-Campelo E, Gonzales-Reimers E, Lope Lirola A: Another rer f rhabd Flanagan DM see Alpert JS Lirola A, Rodriguez-Rodriguez E, Santolaria rivastatin monotherapy (letter FFlieackwmsJa An seDDeJ seeC ui JY ohnstone D Fearstnaauinnd ez therFap y, 5te 93r habdomyolys| is ass GGooroddomna n SMB seseee KDuriiznokna DP Folmar S see Appel LJ Garcia-Valdecasas-Campelo E see Gonzalez-Reimers I Gore JM see Becker RC; Yarzebski J Fonseca R see Rajkumar SV Gardner CD see Ackermann RT Gotto AM Jr: Primary prevention of Ford ES, Liu S: Gl Garside DB see Miura K ve g here lipoprotein chol Gattis WAs ee WhellanD J Gow P], MultimerD : N Gauerke C see Drinka P r) 101 Foreman MD see Inouye SK Gaulden LH see Jiang W; Wheilan Dj Goy A see Turlakow A Forette F see Birkenhager WH Gaziano JM see Lotufo PA Gozzoli V, Schottker P, Suter PM, Ricou B: Is it worth treat Forman S see Reiss MJ Geerlings SE, Stolk RP, Camps MJL, Netten PM, Collet g fever in intensive care unit patients? preliminary re FormosoG , Liberati A, Magrini N: Practice guid JT, Schne eberger PM, Hoepelman AIM: Consequert ts fron r nized trial of the effect of external ful and “participative” method? survey asymptomatic bacteriuria in wome th g ians by professional setting, 203 T tus, 1421 Grady JN see Lyder CH Fossel K see Shadick NA Geerts WH see Attia J Graeme KA see Tanen DA Foster GD, Wadden TA, Phelan S, Sarwer DB, Sanderson Gelberg L see Diamant Al Graham DY, Malaty HM: Alendronate and naproxen are syn RS: Obese patients’ perceptions of treatment outcomes Gelpi AP: America’s health t ic f r development of gastric ulcers, 1 7 orrec and the fact that influence them, 213 Genant HK see Rubin CD tion, 1862 Foucher E see Pouchot J Genés N see Bobrie G Graham DY see Osato MS Fournier A, Oprisiu R, Achard JM: Dif ices between pri Gent M see Ginsberg JS Graham ID see Wilson KG mary vs secondary prevention trials regarding the stroke George V see Hajjar IM Grandi AM, Broggi R, Colombo S, Santillo R, Imperiale protective effect of antihypertensive drugs (letter ) Geurkink EA see Nelson WW D, Bertolini A, Guasti L,V enco A: Left ventricular changes Fowler MB see Jamali AH GhaWA lseei H ull RD n isolated office hypertension: a blood pressure Frampton C see Egermayer P Ghatak AT see Neugut Al matched comparison with normotension and sustained Frances CD, Noguchi H, Massie BM, Browner WS Ghillani M see Dazzi D hypertension, 2677 McClellan M: Are we inhibited? renal insufficiency Ghobrial MW see Kwakwa HA Grand’Maison A see Bates SM should not preclude the use of ACE inhibitors for Ghobrial SS see Singh $ Granger B see Whellan D] ARCH INTERN MED/VOL 161, DEC 10/24, 2001 WWW. ARCHINTERNMED.COM 2754 Grau I see Capdevila O Heiat A. Vaccarino V, Krumholz HM Gravenstein S see Monte AS Gready RM see Ditto PH Greenberg PE see Birnbaum HG Greenfield S see Wilson IB Greenhaff PL see Steenge GR Greenland P see Miura K Hein HO see Jeppesen J Greist JH see Mundt J« Heit J JA, Colwell CW, Francis CW, Ginsberg JS Griffith R see Fielder AR Berkowitz SD, Whipple J, Peters AstraZeneca Grim CE see Hajjar IM Arthroplasty Study Group: Comparison of the Gross CP see Cruz-Correa M Grossman E, Messerli FH, Neutel JM: Angiotensin | ImaiH se receptor blockers: equal or preferred substitutes { imperat ACE inhtbitors?, 160:190 y ( 161.300 Imperial Grundy SM: Non-high-density lipoprotein cholesterol leve Heliovaara M see Knekt P Ingram DD i as potential risk predictor and therapy target, 137° Hellerstein S see Weinberg M Inoue K-i, Yoshikawa T, Kawahito Y, Sano H Grunenberger F see Goichot B Helmerhorst FM see Bloemenkamp KWM r a Guallar E see Erlinger TP Henneberg EW see Frost | Inouye SK, Foreman MD, MionL C, Katz KH, Cooney LM Guasti L see Grandi AM HHeennnneisnsgy JME sseeee WRahledw DDSC Jr { r Gudiol F see Capdevila O Hepburn MJ, Dooley DP, Morris MJ: Effe Inouye SK see AgostiniJ V Guerci B see Latger-Cannard V replacement therapy on airway functior Iqbal HK see KamelH K Guerrero C see Moreno S pausal, asthmatic women Irani SR Gunzenhauser JD see Young SYN Herings RMC see Bouvy MI Iriya SM Gupta A, Thomas AG, Haboubi N: Scr Hertzman PA, Clauw Dj, Duffy J, Medsger TA Jr Lichen lysfun t e elderly (letter) 13¢ Feinstein AR: Rigor new appr r Gurwitz JH see Field TS; McCormick D; Yood RA 4 d j standaar"d tor validating Gus M, Fuchs FD, Pimentel M, Rosa D, Melo AG, Moreira " mplifiedb y the sinoph Isaac DI LB: Behavior of ambulatory blood pressure surrounding episodes of headache in mildly hypertensive patie Hidalgo-Tenorio C see Perez-Alvarez AI Gussekloo J see von Faber M Hilberg T see Ebbesen j Ishikawa H s Guterman LR see Qureshi Al Hill RE see Kuffner EK Israeli A see Gyntelberg F see Jeppe sen | Hiller R see Worzala K Iwata K Hillman B see Wilson IB H Hirschmann JV: What killed Mozart Iwatani Y see Kabutomori© Hirsh ] see Bates SM; Ginsberg JS Haboubi N see Gupta A Hirshbein LD: William Osler and Th Haefeli WE see Schlienger RG ng medical and popular ideas abou Hahn J see Pargament KI Hochberg MC, Schein OD: Dry eyes and Jackevicius CA, AndersoGnM , Leiter L, Tu JV Hajjar IM, Grim CE, George V, Kotchen TA: Impact of diet tients with generalized nodal osteoarthrit nt 1 pressure and age-related changes in blood pres Hochman JS see O'Rourke RA sure in the USp opulation: analysis ofN HANESI ll, 589 Hocqueloux L, Gallien S$, Bornstain C, Molina J-M: ( Jackson Jl Hak E, Hoes AW, Moons KGM, Verheij TJM: Clinical signs ricyclic antidepressar verdosage in a patient with . mptoms predicting influenza infection (lett 12 jer mega-highly active antiretr Jackson JL, Houston JS, Hanling SR, Terhaar KA, Yun JS Halabi S see Bastian LA HoenigL J: Follow-up t a Jewish 7 Hall E see Dart RC Holocaust” (letter) 1460 Halm EA, Simon T, Reichert S: Physicians’ attitudes abou Hoepelman AIM see Geerlings SE Jackson JL see Browning R prescribing and knowledge oft he costs of common medi Hoes AW see Bouvy ML; Hak I Jacobsen BK, Njolstad 1, Thune 1, Wilsgaard T, Lochen Mi ations (letter 5 Hoetelmans RMW see Nieuwkerk PT Schirmer H se in weiahe in oll birth cod Ham H see Rozenberg S Hoff TH, Whitcomb WF, Williams K, Nelson JR ) Hamer DH, Meydani SN Cheesman RA: Characteristics and work experien et 482 f hospitaliisnt tsh e United States, 8 Jacobson TA see Harper CR Hamulyak K see Hull RD Hofmann F see Rieger MA JaiSn se e Field TS Han L, McCusker J, Cole M, Abrahamowicz M, Primeau Holford TR see Avants SK Jamali AH, Tang WHW, Khot UN, Fowler MB: F, Elie M: Use of medicat with anticholinergic effect Holroyd B see Khan SA linical severity jelirium symptoms in older Holstege CP see Sweet JM medical inpatients, 1099 Holzer M see Zeiner A Jambroes M see Nieuwkerk PT Haney L see Kaszuba SM Honkanen PO see Seppa Y Janata K, Kirkciyan 1, Sterz F Hankinson SE see Karlson EW Hopkins LN see Qureshi Al Hanling SR see Jackson Jl Horowitz JD see Massie BM Janolf EN see Carson P Hanna HA see Bodey GP Horowitz M see Bytzer P Janssen WMT see Monster TBM Hanson J see Lawlor PG Houston JS see Jackson Jl jarandilaR see Pires LA Hanson RW see Rothschild JM Houts RM see Ditto PH Jay SJ: Is smok Hansson L, Smith DHG, Reeves R, Lapuerta P: Headache Hrncir Z see Pudil R hypertension, and irbesartan therapy (letter) 776 Hsu K-H see Lin J-l Jecker NS see Schneiderman LJ Hansten P see Bottorff MB Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett Jensen HH see Mortensen El Hanusa BH see Rollman Bi WC, Rimm EB: Physical activity and television watct Jensen PL see Canzanello VJ Haramati A, | umpkin MD: Integrating complementary and ing in relation to risk for type 2 diabetes mellitus Jensen WA see Kearns PJ alternative medicine into conventional medical educa 1542 Jeppesen J, Hein HO, Suadicani P, Gyntelberg fF tion: role of basic science (letier) 1679 Hu FB see Fung TT r high high-density hpoprotein ct Harper CR, Jacobson TA: Fats of life: the role of omega-3 Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC fatty acids in the prevention of coronary heart disease, 2185 Speizer FE, Nathan DM, Manson JE: Impact of diabet Jeral JM see Chibnall JT Harrington JT see Madaio MP mellitus on mortality from all causes and coronary heart Jeune B see Bathum I Harrington S see Golub JE disease in women: 20 years of follow-up, 171 Jiang W, Alexander J, Christopher E, Kuchibhatla MN HHHHHaaaaarrrssztrshifoecioll mrdhod oM tr LonMR s eeKss He e-eeMsM eo eOrY eomseloTledoaa nkn aRdRio AeS g eTTr MA HHHHHHuuuuuulbcaagleknen r ngg R DK,M WP T- sK-W eSPes H eie sn eCeseoeos ees etL GWauLiF nNi,utuiA i WenF YuirY- w-a€ knOce irsk PCTW , Bergvist D, Fellenius ¢ JJiicmkGC aalMuHit H flf ds eees neReM ,S ciLh AHKlu,i reWinCYgsu efhrrfea nseed waiRtntGR M R S,,r iOskn' BgCleosoaftzn iivnmneoo grtr a lhiMetaAyr,C Mt : RfaDnade alavtei1 nopnsohritrpy i ta¢ Havel C see Zeiner A Mah AF, Brant RF: Dalteparin vs warfarin in hip arthre Jimenez J-L see De Jose MI Hawk JC Ill see Tan | plasty patients (letter) 777 Jimenez-Alonso ] see Perez-Alvarez AI Hays J see Zambon M Hull RD, Pineo GF, SteinP D, Mah AF, Macisaac SM, Dahl Johnsen SP see Frost 1 He J, Ogden LG, Bazzano LA, Vupputuri S. Loria CM OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D Johnson L see Strathdee SA Whelton PK: Risk factors for congestive heart failure Hamulyak K, Francis CW, Marder VJ, RaskobG E: Tim JohnsonRW , ArnettF C: Fatal case of in US men and women: NHANES | epidemiologic ingo f initial administration of low-molecular-weight hey entr aS sept arthritis, 261¢ follow-up study, 996 arin prophylaxis against deep vein thrombosis in pa Johnston DWC see Jones CA He ] see Bazzano LA tients following elective hip arthroplasty: a systematic Johnston M see Bates SM Heath A see Camilleri M review, 1952 Johnstone D, FleckmanD J, Berger C: A Heckbert SR, Kaplan RC, Weiss NS, Psaty BM, Lin D Humblot S, Martin T, Pasquali J-L, Korganow A-S: Blood titis after treatment with rabepra Furberg CD, Starr JR, Anderson GD, LaCroix AZ coagulation disorders during primary cytomegalovirus Jones C see Coresh J Risk of recurrent coronary events in relation to use and infection, 2149 Jones CA, Voaklander DC, Johnston DWC, Suarez recent initiation of postmenopausal hormone therapy Hunt SC see Richardson RD Almazor ME: Fiffe of age on pain, functior ] 1709 Hurst JW: lich to write (a personal account) 643 f life after total hip and knee arthroplasty Heckbert SR see Klungel OH Huskins WC see Weinberg M Jones MP see Bytzer P Heerdink ER see Bouvy MI Husted S see Frost L Jones S see Manning P] Heffelfinger JD see Dowell SF Hutchins GM see Sehdev AES Jonsen AR see Schneiderman LJ ARCH INTERN MED/VOL 161, DEC 10/24, 2001 WWW. ARCHINTERNMED.COM 2755 jordan J see I arber NJ Klein HG see Zumber Julian J see Ginsberg JS Kleinman L see Farup ¢ Junod Af see Wicki J Klepfish A, Sch att JuradoR see Franco-Paredes Kliegel A see Ze nerA Klung 1OH Heckbert SF Lon Kabutomori O, iwatani Y, Kanakura Y KaplanR ¢ Smitt NI Lema A, Psaty BM 161 Kahn JP, Mastroianni AC eufkens HGM, de Smith NI Psaty K m M see Breitbar Kal hmayr R see Fir Kalra | see Evans A A, Alfthan Heliov Kamel HK, Iqbal HK Aromaa A Kanakura Y see Kabutomor iO Kanit akis |] see Choque Kastyle vsky ( Kannel WB se Seshadri S Kanterewicz E, Y anez A Kaplan GA see Kaplan NM Ulkar UGB -argament KI Kaplan RC see Hec kbert SR: Klung KohlwesR J Kaplan S see Wilson IB Bazzarre T, Mosca | Kapoor WN see R : an BI WA Kap huk T] see Cherkir m™ Karala MT see Dumot JA Karcic AA see Karcic Karcic E, Karcic AA Karlson EW Tanasijevic M Hankinson $ Goldstein NM Colditz GA Sp izer FE Schur PH see Humblot $ Nakaraura HK, Wada ¥ Karson AS see Abookire SA Kase CS see Seshadri $ Avants SK Kassimos DG, Panayl GS, Challacombe S$ Hajjar IM outamaaM , pP eltonen R, I S, Vuopio-Varkila J, Ross Haney L., Blair ¢ Katz KH see SK Kauffmann F see Zureik ik M Kauffmann RH see Nieuwkerk PT Kawahito Y see I] noue. K-i Kearns Pj, Wang CC. Low D¢ KearnsP J Wang C( Morris W] Chan SY JensenW A Keene O s Lale zari J Zambon M Kelleher M Kelly-HavyesM se« Seshadri § KeougJh s ee D'Elia JA Kerr EA set Asch SM Khan As ee Lanki valli RS Khan SA de Geus C, Holroyd B Abr amson J; Heiat A Khan SA see Russell AS RA Khardon R Kuchibhatla MN see Bastian LA; JiangV Khardori R, Abraham M KufDtanre ton EK,| Dart RC, Bogdan GM, Hill I Khorasani R see Rothschild JM Khot UN see Jamali AH Kim C. Seidel KW, Begier EA, Kwok YS Kuhanen f see Laukkanen JA Kuizon D, G »rdon SM, Dolmatch BI b kevicius ( KimmelS E see Kizer JR see Hu FE Kirsner RS see Federman D¢ KisheM lse e Armour BS Kuller LH see Psaty BM Kitagawa Y see Fukui M Kumar PD see« Ravakhah K Kitchens CS see Dart RC; Zumberg } Kumar PD Solti M Kitching AD see Tsuyuki RT Kizer JR, Kimmel SI Kunin CM see Liu Y-« Kuntz KM see Shadick NA Kurishima K see Satoh H an up-to-d " rspective the proy 1 hazard } Kurkciyan I see Janata K Kjoller K, Friis § Mellemkjar L, McLaughlin JK Kutting 3 se Brehler R Albrecht H Winther Jf Lipworth L, Blot WJ, Fryzek J Olsen JH Kwakwa HA, Ghobrial MW: I IW see Linden W ect disease at her rl , " Summers LS see Agostini J\ ions following metic brea plantat KwoYSk s ee Kim (¢ eon-Ruiz | see Perez Aly arez AT Denmark KwongY L, Au WY ncer antiget ) 1 one Girmenia ( Kladosek As ee Finsterer ] ke a ssard D see Yarzebski | Klag MJ see Coresh J] KwongY L see Au WY fkens HGM see Bouvy MI Klunge!lO H ARCH INTERN MI D/ VOL 161, DEC 10/24, 2001 2756 1 wufo PA see Bensetx M As¢ ha EJ see Dumot JA yw DG see Kearns I Mass| saeer Llooyd -} mes DM HJ see Rollman BI BM, Armstrong PW. Cleland IGF_H uno FW see Weinberg M ' M Pocle-Wilson PA, Ryder i Lucore CL se O'Rourke RA LuengoL M see Luna \ L-Y see Yalle K Monster TBM, Janssen WMT, de Jong-van der Berg LTW Nelson KE see Strathdee SA Salakhov E, Ronen I, BergD , Israeli A: Manag Prevention of Renal and Vascular End Stage Disease Nelson WW, Vermeulen LC, Geurkink EA, Ehlert DA hypokalemia nt ' y Group, de J yng PE nelderfer M: | al and eth } 1 t t to “theray R at Kassimos DG Monto AS, GravensteinS , Elliott M, Colopy M, Schweinle Netten PM see Geerlings SE N see Chehab El J NeuAlg, Guhattak AT, MillerR L: Anaphy see Di NapoliM tion intoi ts epiden I see Péne f Moons KGM see Hak I Neugut Al, Miller RL, Ghatak AT: Ur rameswaran H see Lankipalli RS Moore K see Golub JI 2 r ler ot anaphylaxi zament KI, Koenig HG, Tarakeshwar N, Hahn J: Rel Moore M see Dedier J Neuhaus]M see Avins Al a pre r of mortalit r g! Morales F see Luna V Neutel JM see Grossman E atic a a r Moran MB Nevin WS aving feature rish DC see Chandra KMD rk |,W hite AR, Ernst F Morazzoni P see Mennini 1 Nevitt M see Yaffe K Morbidoni L see Ackermann RT Newman R see Zambon M see Weinberg M Moreira LB see Gus M Newman T see Lacasse Y A see Lemieux I Morelon S, Harzic M, Chadenat M-1 Nexo E see Hvas A-M see Humblot S I ry infe with Niazi AF see Ebright JR sos S see Eron LJ Nichol KI seer rick DI see Curtis JR Moreno H Jr see Tanus-SantosJ E lik V see Hyman DJ Moreno S, Blazquez R, Novoa A Nichol KL see Carson P: I arlman RA see Kohlwes RJ A, Ramirez C, Guerrero C: f Nichol KL, Zimmerman R: Gener arson SD see Pereira A ltor R see Kotilainen P ndse S see D'EliaJ A Moreno-John G see LotufoP A F, Papo T, Brudy-GulpheI Morley M see Birnbaum HG Nielsen NH see Tan I Vinsonneau ( I k Morris J see Meier DE Nienaber CA Morris MJ] see Hepburn MJ Morris W] see Kearns P] Nieuwkerk PT, Sprangers MAG, Burger DM, Hoetelmar and RL see OsatoM S Morrison RS see Meier DI RMW, Hugen PWH, Danner SA, van der Ende MI nx BWJH, MessierS P, RejeskiW J, WilliamsonJ D Mortensen EL, Jensen HH, Sanders SA, Reinisch JM Schneider MME, Schrey G, Meenhorst PL, Sprenger H DiBari M, Cavazzini C, Applegate WB, PahoM:r P t Kauffmann RH, Jambroes M, Chesney MA, de olf I andlt he ne ' £ disability in act Lange JMA, ATHENA Project: Limit Mosca L: k Mosca L see Koffman DM Njolstad I see Jacobsen BK Lawlor PG Moser M Noél B:f rg ease Or arse s A see Wu AW NoguchHi s ee FrancesC D Pérez A, Wagner AM, Carreras ( Nogués A see Falguera M North American Society of Pacing and Electroy a mr ogy (NASPE) Practice Guideline Committee AF. Jiménez-Alonso ], Reche-Molina I Mosier MC see Ziegler DK Goldschlager N Hidalgo-Tenorio ©, Sabio JM: Retina Moskowitz M see Worzala K Northcutt AR see Camilleri M MoveJrPs s ee Branca I Novoa A see Moreno $ Mraovic B see Dumot JA Nuytinck L see Loeys B Muder RR see Vergis EN Nybo H see Bathum I y ar er Mulrow CD see Ackermann R1 Nzeako UC, Frigas E, Tremaine W]: H er TV see EtterJ- F; Wicki J Multimer D see Gow PJ r clir 4. Bounameaux H, Wicki J Mundt JC, Ferber KL, Rizzo M, Greist JH le Moerloose P, Bounameaux H Mufoz P, Blan t. Rodriguez-Creixéms M, Garcia I Ybasanjo OO see Golub JE Delcan ist O'Brien PE see Dixon JB : gic pr O'Connor CM see Jiang W; Whellan D] Wicki J Munoz-Fernandez MA see De Jose MI O'Connor E see Markson LE \-E see Andres f Munoz-Furlong A see Sicherer SH O'Connor PG see Fiellin DA rrinSDo s ee ClaudioG A Murabito JM see Worzala K ‘ » P] see Martinson BC ng DH see Gomes-Solecki MJ¢ Murphy TF see Tavar R O'DonneCljl s ee Lloyd-JonesD M see Baron JA Murtaza M, Singh M, Dimitrov V OfmJJ aseen Fas s R;R hewD C; Spiegel BMI an-Chaney SE see Ashley JM Ogden LG see Bazzano LA; He J} Heit JA Musher DM, BartlettJ G, DoernG Y Ohtsuka M see Satoh H Bathum I Okuyemi K see Ziegler DK NallamothuB K YLeary DH see Psaty BM 4 see Dazzi D Must A see Field Al Olsen JH see Kjoller K Foster GD Mutalik K see Worzala K Olshansky Bs ee Goldschlager Myers L see Bazzano LA O'Malley PG see Browning R Mylonakis E, Ryan ET, Calderwood SB Omland T, Hartford M, Caidahl K: M ee Shadick NA lliLpSs s ee El-Kebbi IM; Miller CD etter + rilliz S see Wee C( N Onder G, Bernabei R, Cesari M, Gambassi ( LS see TsuyukiR T r 7 1 i} sf Y Naclerio RM see Kaszuba SM Naganathan V, Sambrook P Onder G see Landi F Péne Ff Oprisiu R see Fournier A M O'Rourke RA, HochmanJ S, Cohen MC, Lu Pimentel M see Fass R: Gus M NagaSr s ee SmegRoA J jj, Cannon CP P GF see Hull RD Naguit I see Bates SM F A. Ganji JR, Jarandila R, Steele R Nakamura HK see Koshiyama H nfa 1 my al trend he evaluat Nakamura N see Fukui M Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM pitalized with syncope, 1889 Nallamothu BK, Saint S, Bielak LF, Sonnad SS. Peyser PA Graham DY: Pattern of primaryr e {fH } Pirro M, Bergeron J, Dagenais GR, Bernard P-M, Cantin Rubenfire M, Fendrick AM: Electron-bean 'p ’ metr idazole or clarithr B, Després J-P, Lamarche B: Age and duration of fol . noduolf thae rtisko forr issche mic heartd eta-analysis, 8 Osterberg L see Lipinski M iated with high plasma Nal lamothu BK, Saint S, Rubenfire M, Fendrick AM: I ron-bear I J tomography as a poy a Pittler MH see Ernst I ing t etter) 262 Pitts MM see Armour BS Narayanan S see Markson LE Pace MT see Ebright JR Pometta R see Fraquelli M Nasca TJ, Veloski JJ, Monnier JA, Cunningham JI Packer M see Massie BM Poole-Wilson PA see Massie BM Valerio S, Lewis TJ, Gonnella JS: Mir Padilla R, Gomez V, Biggerstaff SL, Mehler PS Popara M see Smego RA Jr tional and program-specific adn lerismo in a public health care system ( Pope DS see Golub JI educating residents in int Pagano L see Girmenia ( Popma Jj see O'Rourke RA Nathan DM see Hu FB Pahor M see Penninx BWJH Porath A see Dreiher J National Registry of Myocardial Infarction Participants see Pak CYC see Rubin CD Porter RS see Dart R¢ Becker R« Pallares R see Capdevila O Pouchot J, Foucher E, Lino M, Vinceneux P, Barge J: Granu Negro R see Dazzi D Palmer JR see Rosenberg I at mastitis: an uncommon cause of breast abscess Nelson JR see Hoff TH Palita M see Young T ARCH INTERN MED/VOL 161, DEC 10/24, 2001 WWW. ARCHINTERNMED.COM 2758